A mega-analysis published Monday in Nature Medicine pooled 11 independent resting-state fMRI datasets covering five classic psychedelics — psilocybin, LSD, mescaline, DMT and ayahuasca — from 267 participants across five countries and more than 500 brain-scanning sessions.
Study: Psychedelics Share a Common Brain 'Fingerprint'